2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1721

Investigating the SCF/c-Kit Pathway in Scleroderma Fibrosis
Abstract Number: 429

Investigation of MRI Bone Changes in Early-Stage RA Patients Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort
Abstract Number: 2326

Investigation of Parameters Used to Test Quadriceps Muscle Power Using Isokinetic Dynamometer in Arthritis
Abstract Number: 1414

Investigation of the Association Between Gastroesophageal Reflux Disease and Clinical Factors in Patients with Rheumatoid Arthritis
Abstract Number: 2069

Investigation of the Effects of Physical Exercise on the Control Mechanisms of Cutaneous Circulation in Patients with Fibromyalgia Syndrome
Abstract Number: 1812

Investigation of the Sting/Interferon Pathway Activation in a Novel Vasculopathy and Pulmonary Syndrome
Abstract Number: 2849

Involvement of CD8⁺ T Cells in the Pathogenesis of Giant Cell Arteritis and Polymyalgia Rheumatica
Abstract Number: 1746

Involvement of IL-17-Producing MAIT Cells in the Pathogenesis of Rheumatoid Arthritis
Abstract Number: 1228

Involvement of the IFN-Õ Pathway in a Patient with Candle Syndrome Carrying a Novel Variant of PSMB8 Gene
Abstract Number: 529

IP3R3 Deficit Underlies the Loss of Fluid Secretion in Salivary Glands from Sjögren’s Syndrome Patients
Abstract Number: 762

IQGAP1 Enhances Contractility of Scleroderma Lung Fibroblasts and Promotes Bleomycin-Induced Pulmonary Fibrosis
Abstract Number: 870

IRF1 Influences on Histone H4 Acetylation in Systemic Lupus Erythematosus
Abstract Number: 1130

IRF8 Gene Contributes to Disease Susceptibility and Interacts with NF-KB By Modulating Interferon Signature in Patients with Systemic Sclerosis
Abstract Number: 228

Is Adult Hypophosphatasia a Cardiovascular Risk Factor?
Abstract Number: 2936

Is Ankylosing Spondylitis a Risk Factor for Cardiovascular Diseases, and How Does These Risks Compare to Those in Rheumatoid Arthritis?

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].